[Page Banner Image]

The information is updated the first week of every month - so ... make this a regular stop in your information gathering activities.

The following information has been compiled from publicly available sources, StratCom does not assume any responsibility for the accuracy or the authenticity of the information and StratCom cannot be held liable for errors.

[HRule Image]

Molecular Biology — December 2004

Dear Reader, We wish you all the best for 2005 - May we all live in health, peace and prosperity.

Affymetrix Inc. received FDA clearance to market the Affymetrix GeneChip System 3000Dx (GCS 3000Dx), an instrumentation system to analyze IVD microarrays. This is the first microarray instrument to be cleared by the FDA for IVD use. The FDA clearance of the Affymetrix GCS 3000Dx follows the August ISO certification of the instrument and array manufacturing facilities and the September IVD CE marking of the instrument system in the European Union. Affymetrix collaborates with its Powered by Affymetrix partners to develop genotyping and gene expression diagnostics on the GCS 3000Dx system.

Affymetrix Inc. granted Veridex, LLC, a Johnson & Johnson company, long-term and comprehensive access to its GeneChip technology to create and market in-vitro diagnostics for cancer. The agreement, made under the Powered by Affymetrix program, gives Veridex non-exclusive rights to Affymetrix' patented arrays, instrumentation systems and planned improvements to these key technologies.

Genomic Health Inc. developed the Oncotype DX Recurrence Score Assay used to predict which breast cancer patients are at risk for distant recurrence and which patients will benefit from tamoxifen or chemotherapy. Recurrence score measures the expression of 21 genes (16 directly related to cancer development and five included as reference genes), and converts the measurements into a score ranging from one to 100. Based on the recurrence score, patients can be rated as low risk (score less than 18), intermediate risk (score between 18 and 30), or high risk (score greater than 30) for distant recurrence.

Stratagene Corporation launched the Mx3005P Real-Time PCR System, the latest in the company's line of QPCR instrumentation. The system is an open platform design that supports all fluorescent dyes and chemistries including Stratagene's proprietary FullVelocity reagents. The U.S. list price for the Mx3005P is $29,900.

[HRule Image]

* Molecular Biology - November 2004
* Molecular Biology - October 2004
* Molecular Biology - September 2004
* Molecular Biology - Summer 2004
* Molecular Biology - May 2004
* Molecular Biology - April 2004
* Molecular Biology - March 2004
* Molecular Biology - February 2004
* Molecular Biology - January 2004
* Molecular Biology - November 2003
* Molecular Biology - October 2003
* Molecular Biology - September 2003
* Molecular Biology - May 2003
* Molecular Biology - April 2003
* Molecular Biology - March 2003
* Molecular Biology - April 04003
* Molecular Biology - January 2003
* Molecular Biology - December 2002
* Molecular Biology - November 2002
* Molecular Biology - October 2002
* Molecular Biology - September 2002
* Molecular Biology - Summer 2002
* Molecular Biology - June 2002
* Molecular Biology - May 2002
* Molecular Biology - April 2002
* Molecular Biology - March 2002
* Molecular Biology - April 04002
* Molecular Biology - January 2002
* Molecular Biology - December 2001
* Molecular Biology - November 2001
* Molecular Biology - October 2001
* Molecular Biology - September 2001
* Molecular Biology - Summer 2001
* Molecular Biology - May 2001
* Molecular Biology - April 2001
* Molecular Biology - March 2001
* Molecular Biology - April 04001
* Molecular Biology - January 2001
* Molecular Biology - December 2000
* Molecular Biology - November 2000
* Molecular Biology - October 2000
* Molecular Biology - September 2000
* Molecular Biology - July - August 2000
* Molecular Biology - June 2000
* Molecular Biology - May 2000
* Molecular Biology - April 2000
* Molecular Biology - March 2000
* Molecular Biology - Febuary 2000
* Molecular Biology - January 2000
* Molecular Biology - December 1999
* Molecular Biology - November 1999
* Molecular Biology - October 1999
* Molecular Biology - September 1999

[HRule Image]

Home | Company Profile | Services | Research Reports Available
Product Developments Worldwide | Research News | Health Care in Canada
Information Technology and Healthcare | Molecular Biology | Links

[HRule Image]
Send mail to stratcom@pagebleu.com with questions or comments about this web site.

Concept and Design Blue Page Productions
Copyright © 1996-2005 STRATCOM

Last modified: January 3, 2005